Jiangsu Nhwa Pharmaceutical Co Ltd Capital Reinvestment Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd capital reinvestment ratio. Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥425.83 Million) in capital expenditures (CN¥80.95 Million). Check 002262 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Capital reinvestment ratio of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. This chart tracks Jiangsu Nhwa Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 21 annual periods. Also explore Jiangsu Nhwa Pharmaceutical Co Ltd (002262) net asset momentum to track the company's year-over-year net asset growth rate.
Jiangsu Nhwa Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2005–2025)
Jiangsu Nhwa Pharmaceutical Co Ltd capital reinvestment ratio by year from 2005 to 2025. For the full cash flow conversion analysis, see 002262 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.41x | CN¥1.08 Billion | CN¥437.41 Million | ▼ -17.4% |
| 2024 | 0.49x | CN¥916.13 Million | CN¥450.06 Million | ▲ +32.4% |
| 2023 | 0.37x | CN¥1.01 Billion | CN¥373.99 Million | ▼ -2.6% |
| 2022 | 0.38x | CN¥861.02 Million | CN¥327.75 Million | ▲ +29.5% |
| 2021 | 0.29x | CN¥701.12 Million | CN¥206.11 Million | ▲ +36.6% |
| 2020 | 0.22x | CN¥1.25 Billion | CN¥268.61 Million | ▼ -58.9% |
| 2019 | 0.52x | CN¥305.97 Million | CN¥160.30 Million | ▲ +24.2% |
| 2018 | 0.42x | CN¥404.52 Million | CN¥170.70 Million | ▲ +15.0% |
| 2017 | 0.37x | CN¥452.35 Million | CN¥166.01 Million | ▼ -0.5% |
| 2016 | 0.37x | CN¥277.14 Million | CN¥102.22 Million | ▼ -65.2% |
| 2015 | 1.06x | CN¥204.24 Million | CN¥216.63 Million | ▼ -35.0% |
| 2014 | 1.63x | CN¥160.24 Million | CN¥261.60 Million | ▲ +206.2% |
| 2013 | 0.53x | CN¥194.33 Million | CN¥103.63 Million | ▲ +5.4% |
| 2012 | 0.51x | CN¥154.16 Million | CN¥78.01 Million | ▼ -11.2% |
| 2011 | 0.57x | CN¥81.08 Million | CN¥46.21 Million | ▼ -58.8% |
| 2010 | 1.38x | CN¥61.79 Million | CN¥85.57 Million | ▲ +101.3% |
| 2009 | 0.69x | CN¥61.27 Million | CN¥42.15 Million | ▼ -14.5% |
| 2008 | 0.80x | CN¥46.50 Million | CN¥37.40 Million | ▼ -6.9% |
| 2007 | 0.86x | CN¥48.55 Million | CN¥41.96 Million | ▼ -25.8% |
| 2006 | 1.16x | CN¥30.99 Million | CN¥36.09 Million | ▼ -67.8% |
| 2005 | 3.62x | CN¥8.84 Million | CN¥31.99 Million | — |